13 june, 2024
We are proud to share an unequaled level of requirement in our organization, surpassing regulatory standards to deliver excellence.
As a world leader in the healthcare industry, product quality is not just a requirement but an absolute obligation for us.
Our new Quality Policy is rooted in the foundational values of HTL Biotechnology.
It is forward-looking, embodying our leadership’s dedication ๐ญ๐จ ๐๐ง๐ฌ๐ฎ๐ซ๐ข๐ง๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐๐ซ ๐ฌ๐๐ญ๐ข๐ฌ๐๐๐๐ญ๐ข๐จ๐ง ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐ฏ๐, ๐ฌ๐๐๐, ๐๐ง๐ ๐๐๐๐๐๐ญ๐ข๐ฏ๐ ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ.
๐
To see our most recent news,
Read more
news from us
-
Articles July 5, 2024
HTL Biotechnology Secures Medical Device Registration in China
Sodium DNA Raw Material Main Document (Polynucleotides) registered as a medical device (number M2024199-000) in China.
-
Articles June 21, 2024
HTL Biotechnology at CPHI China 2024
CPHI China is one of Asiaโs leading Pharma events for trading and networking with 3,500+ exhibitors and 90,000+ professionals from the pharmaceutical industry,
-
Articles June 5, 2024
National Bioproduction and Biomedicine Day (TVR report)
On the occasion of the first National Bioproduction and Biomedicine Day, which took place on the last 5th july, we were very proud to welcome a TVR journalist in our Javenรฉ site for an exclusive report.